Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its ...

US clinical stage biotech Alector saw its shares tumble 35% to $2.57 by close of trading yesterday, as it announced ...

Alector stock falls as the phase II INVOKE-2 study evaluating AL002 in slowing disease progression in early Alzheimer's disease fails to meet the primary goal.

H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating ...

After trading closed yesterday, Exelixis revealed that the US Food and Drug Administration (FDA) has notified the company ...

At least 19 people in Minnesota have been sickened by E. coli O157:H7 tied to a national recall of more than 167,000 pounds of potentially tainted ground beef, federal health officials said.

A brawl erupted between a Thai transwoman and a foreign man at a hotel in Phuket after the foreigner refused to pay upon discovering her gender. A source, who wishes to remain anonymous, reported the ...